Other top stories

In Surprise Comeback, Gymnast Simone Biles Looks to Triumph Over Anxiety

June 29, 2023

How Brain Chemical Imbalances May Contribute to OCD

June 28, 2023

Brain-Targeting Drug Similar to Ozempic Shows Promise in Parkinson's

June 27, 2023

FDA Releases First-Ever Draft Guidance on Psychedelic Drug Research

June 26, 2023

The Weekly Mind Reader: AI-Driven Suicide Prediction

June 23, 2023

Emerging Treatment Approaches for Schizophrenia Show Promise

June 22, 2023

Other stories

Donald Triplett, Autism 'Case 1', Passes Away at Age 89

June 21, 2023

Singer-Songwriter Ren’s Raw Depictions of Mental Health Strike a Chord

June 20, 2023

The Weekly Mind Reader: Clinical Trial Disparities

June 16, 2023

5 Minute Pearls: Psychiatric Disorders, Psychedelic Therapies, and Expanding Treatment Options

June 15, 2023

Millions Still Have Not Regained Sense of Smell, Taste After COVID

June 14, 2023

FDA Advisory Panel Backs Leqembi for Alzheimer's Treatment

June 13, 2023

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe